Premium
Cost‐effectiveness of longitudinal surveillance for Piscirickettsia salmonis using qPCR in Atlantic salmon farms ( Salmo salar ) in Chile
Author(s) -
Delphino Marina K. V. C.,
Mardones Fernando O.,
Neumann Heise Joaquin,
Gallardo Alicia,
Jimenez Daniel,
Peña Andrea,
RozasSerri Marco,
Gardner Ian A.
Publication year - 2021
Publication title -
journal of fish diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 85
eISSN - 1365-2761
pISSN - 0140-7775
DOI - 10.1111/jfd.13285
Subject(s) - salmo , biology , fishery , sampling (signal processing) , fish <actinopterygii> , engineering , filter (signal processing) , electrical engineering
Costs of diagnostic testing including sample collection, sampling frequency and sample size are an important consideration in the evaluation of the economic feasibility of alternative surveillance strategies for detection of infectious diseases in aquatic animals. In Chile, Piscirickettsia salmonis is the primary reason for antibiotic treatments in farmed Atlantic salmon. In 2012, a surveillance and control programme for piscirickettsiosis was established with an overall goal of reducing antibiotic use. The present study estimated the cost‐effectiveness of different sampling frequencies and sample sizes to achieve at least 95% confidence of early detection of P. salmonis at the netpen and farm levels using a validated qPCR test. We developed a stochastic model that incorporated variability in test accuracy, within‐pen prevalence and sampling costs. Our findings indicated that the current piscirickettsiosis surveillance programme based on risk‐based sampling of five moribund or dead fish from 2 to 3 netpens is cost‐effective and gives a high probability of detection of P. salmonis in Atlantic salmon farms in Chile at both the netpen and farm levels. Results from this study should incentivize salmon farmers to establish cost‐effective strategies for early detection of P. salmonis infection and the application of this approach to other highly infectious diseases.